Charlotte Mary Griffiths-Jones
23Patents
7h-index
70Co-inventors
68Inventor score
Filing activity: Dec 21, 2007 → Dec 21, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8895745B2 | Bicyclic heterocyclic compounds as FGFR inhibitors | Chemistry; Metallurgy | 24 | Active |
| US8071614B2 | Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors | Human Necessities | 14 | Active |
| US9018214B2 | Bicyclic heterocycle compounds and their uses in therapy | Chemistry; Metallurgy | 13 | Active |
| US9676768B2 | Bicyclic heterocycle compounds and their uses in therapy | Chemistry; Metallurgy | 8 | Active |
| US9783538B2 | Bicyclic heterocycle compounds and their uses in therapy | Human Necessities | 7 | Active |
| US8859582B2 | Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors | Human Necessities | 7 | Active |
| US8076354B2 | Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors | Chemistry; Metallurgy | 7 | Active |
| US8513276B2 | Imidazo[1,2-a]pyridine compounds for use in treating cancer | Chemistry; Metallurgy | 6 | Active |
| US10457669B2 | Benzolactam compounds as protein kinase inhibitors | Chemistry; Metallurgy | 4 | Active |
| US10618895B2 | Bicyclic heterocycle compounds and their uses in therapy | Human Necessities | 4 | Active |
| US11001575B1 | Benzolactam compounds as protein kinase inhibitors | Chemistry; Metallurgy | 3 | Active |
| US11225476B2 | Bicyclic heterocycle compounds and their uses in therapy | Human Necessities | 3 | Active |
| US11603367B2 | Isoindolinone inhibitors of the MDM2-P53 interaction and process for making them | Chemistry; Metallurgy | 2 | Active |
| US8796244B2 | Imidazopyridine derivatives as inhibitors of receptor tyrosine kinases | Chemistry; Metallurgy | 1 | Active |
| US11643410B2 | Bicyclic heterocycle compounds and their uses in therapy | Human Necessities | 1 | Active |
| US11866428B2 | Bicyclic heterocycle compounds and their uses in therapy | Chemistry; Metallurgy | 1 | Active |
| US10364256B2 | Biaryl pyrazoles as NRF2 regulators | Chemistry; Metallurgy | 1 | Active |
| US11059816B2 | Ether linked triazoles as NRF2 activators | Chemistry; Metallurgy | 0 | Active |
| US12091409B2 | Ether linked triazoles as NRF2 activators | Chemistry; Metallurgy | 0 | Active |
| US8859583B2 | Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10351530B2 | Arylcyclohexyl pyrazoles as NRF2 regulators | Chemistry; Metallurgy | 0 | Active |
| US12202828B2 | Bicyclic heterocycle compounds and their uses in therapy | Human Necessities | 0 | Active |
| US11939321B2 | Benzolactam compounds as protein kinase inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.